Title CEO Company Bio-Light Life Sciences Investments Bio Mrs. Suzana Nahum-Zilberberg is the CEO of BioLight Life Sciences Investments which invest in, manages and commercialized biomedical innovations grouped into “clusters” around defined medical conditions. BioLight is currently operating two clusters, one around Ophthalmology and the other around Cancer diagnostics. Biolight is traded on the TASE : BOLT and on the OTCQX : BLGTY. Previously Mrs. Nahum-Zilberberg worked at Teva Pharmaceuticals Industries Ltd for 12 years in several leading positions, her last role being Vice President Asia and Pacific, leading the penetration of Teva into Japan and China. In her position Mrs. Nahum-Zilberberg led the JV agreement with Kowa Pharmaceutical in 2008 and the acquisition of Taisho Pharmaceutical in 2009, leading Teva to become the fifth largest generic company in Japan. Mrs. Nahum-Zilberberg holds a BA in Accounting and Economics from Tel Aviv University, MBA in Finance and Marketing from Tel Aviv University and is certified CPA.